San Rafael, CA-based BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for life-threatening severe medical conditions, mainly for children.

Alvotech and Advanz Pharma announce positive EMA opinion for AVT06, a biosimilar to Eylea®, advancing access for eye disorder treatments in Europe.

US tariffs on goods coming from Europe, China, and Canada could have a major impact on the biopharma industry and medicines access, says BIO.

Amid the recent increase in pharmaceutical, bio, and health functional food companies seeking to enter Japan, the Intellectual Property Specialized Committee of the Korea Pharmaceutical and Bio ...

Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol) ...

BridgeBio Pharma will host a webinar on limb-girdle muscular dystrophy with Dr. Matthew Wicklund on July 11, 2025.

BOSTON — Samsung Biologics announced plans Wednesday to further broaden its customer base, aiming to serve the world’s top 40 pharmaceutical companies up from t ...

Nutrient deficiencies may cause hair loss, so multivitamins may be better for hair growth than traditional hair supplements. Biotin, selenium, zinc, vitamins A, B, C ...

Nanjing Deheng Pharmaceutical Technology Co. Ltd. and Nanjing Delova Biotech Co. Ltd. have discovered new sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers reported to be useful for ...